Tesamorelin is a synthetic research peptide designed to mimic the activity of Growth Hormone-Releasing Hormone (GHRH). It functions by signaling the pituitary gland to stimulate the natural release of growth hormone (GH).
In laboratory and research environments, Tesamorelin is primarily studied for its role in growth hormone regulation and its influence on various metabolic pathways.
Growth Hormone-Releasing Hormone (GHRH) is a peptide produced in the hypothalamus. Within research models, GHRH is known to:
Because naturally occurring GHRH is rapidly broken down in the body, researchers have developed more stable analogues, such as Tesamorelin, to allow for extended observation and study.
Research has shown that Tesamorelin binds to GHRH receptors on the pituitary gland, triggering an increase in endogenous growth hormone secretion.
This elevation in GH has enabled researchers to study downstream effects, including:
(Reference: Falutz et al., 2010)
One of the most extensively studied areas of Tesamorelin research involves its impact on visceral adipose tissue. Multiple studies have observed reductions in abdominal visceral fat, while subcutaneous fat levels remain largely unaffected.
(Reference: Stanley et al., 2011)
Unlike some growth hormone–related peptides that may negatively influence glucose metabolism, Tesamorelin has been observed in certain research models to have minimal or neutral effects on insulin sensitivity. This characteristic makes it a key compound of interest in metabolic research.
(Reference: Guaraldi et al., 2012)
All products sold by DTC Labs are intended strictly for laboratory research purposes only.
These products are not intended for human or animal consumption and are not for medical, diagnostic, therapeutic, or clinical use.
The information provided on this website is for educational and informational purposes only.
Reach out and get a response within minutes.
